The Renaissance of “Magic Bullets”: Navigating the Complex Landscape of Next-Generation ADC Development
More than a century ago, Paul Ehrlich proposed the concept of the “magic bullet”—a drug that could selectively target disease-causing agents without harming the host. Today, Antibody-Drug Conjugates (ADCs) are the closestRead More…
